Clinical Trials Logo
  1. Home
  2. Pulmonary Tuberculoses
  3. NCT05097638

Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.

Pulmonary Tuberculoses Clinical Trial

Official title:
Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.

Clinical Trial Summary

Some of pulmonary tuberculous patients who completed their medication course experience lung function impairment

Clinical Trial Description

Some of pulmonary tuberculous patients who completed their medication course experience lung function impairment which may influence their quality of life. However, the pattern and nature of post-tuberculosis lung impairment is still not identified. Thus, the aim of this study was to determine the type and degree of lung physiology changes in previously treated tuberculous patients which latter may affect their quality of life; thus helping clinicians for early diagnosis of lung impairment, especially in tuberculous endemic areas. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05097638
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date January 20, 2018
Completion date February 4, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT04085133 - Prevalence and Burden of Bronchiectasis in Tuberculous Patients
Recruiting NCT05017324 - Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial N/A
Completed NCT04207112 - Economic Evaluation of New MDR TB Regimens Phase 2/Phase 3
Completed NCT04044001 - BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) Phase 1/Phase 2
Withdrawn NCT03159975 - Safety and Immunogenicity Study of GX-70 in TB Patient Phase 1
Completed NCT02984579 - Line Probe Assay Evaluation Study N/A
Completed NCT05568368 - Time-to-Detection in Culture of Mycobacterium Tuberculosis
Recruiting NCT04930978 - Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Not yet recruiting NCT05477966 - A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
Active, not recruiting NCT05045391 - Pulmonary Aspergillosis in Tuberculosis Patients
Completed NCT02754765 - Evaluating Newly Approved Drugs for Multidrug-resistant TB Phase 3
Active, not recruiting NCT03896685 - Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) Phase 3